Meiyu Duan

786 citations
42 papers · 482 indexed · h-index 11
Topics
Gene expression and cancer classification (14 papers)Machine Learning in Bioinformatics (7 papers)Cancer-related molecular mechanisms research (7 papers)

In The Last Decade

Meiyu Duan

40 papers receiving 469 citations

Peers

Meiyu Duan
Comparison fields: 5 of 96
  • Molecular Biology 164
  • Radiology, Nuclear Medicine and Imaging 144
  • Artificial Intelligence 137
  • Cognitive Neuroscience 50
  • Infectious Diseases 44
Replace Lijing Wang with:
Lijing Wang United States
Abedalrhman Alkhateeb Canada
Zhanhao Mo China
Benjamin Ulfenborg Sweden
Duyen Thi Taiwan
Truong Nguyen Khanh Hung Vietnam
Yiming Zhou China
Zhuo Liu China
Karsten Wendt Germany
Meiyu Duan relative to Lijing Wang United States Lijing Wang's profile →
Citations per field
00.5×2.9×
Lijing Wang · 1×
Citations per year

Countries citing papers authored by Meiyu Duan

Since Specialization
Citations

This map shows the geographic impact of Meiyu Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiyu Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiyu Duan more than expected).

Fields of papers citing papers by Meiyu Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiyu Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiyu Duan. The network helps show where Meiyu Duan may publish in the future.

Co-authorship network of co-authors of Meiyu Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Meiyu Duan. A scholar is included among the top collaborators of Meiyu Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiyu Duan. Meiyu Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 5
4 3
5 2
6 2
7 1
8 8
9 11
10 5
11 6
12 19
13 2
14 14
15 6
16 5
17 6
18 86
19 10
20 54

About Meiyu Duan

Meiyu Duan is a scholar working on Cancer Research, Molecular Biology and Computational Theory and Mathematics, having authored 42 papers that have together received 482 indexed citations. Recurring topics across this work include Gene expression and cancer classification (14 papers), Machine Learning in Bioinformatics (7 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Health Informatics (21 citations), Health Information Management (34 citations) and Radiology, Nuclear Medicine and Imaging (144 citations). Meiyu Duan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Fengfeng Zhou, Lan Huang, Shuai Liu, Xin Feng, Guoqing Wang, Ejun Peng, Juanjuan Huang, Yingli Zhang, Yueying Wang and Zhaomin Yao. Their work appears in journals such as Bioinformatics, International Journal of Molecular Sciences and IEEE Access.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026